U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
6891168911Substrate Oxidation in Children in Response to High and Low Dairy IntakeCompletedNo Results AvailableChildhood ObesityDietary Supplement: Dairy Products|Dietary Supplement: Dairy Servingshttps://ClinicalTrials.gov/show/NCT01664702
6891268912Intraoperative and Postoperative Outcomes of Three Ophthalmic Viscosurgical Devices During PhacoemulsificationCompletedNo Results AvailableIntraoperative Performance and Postoperative Outcomes Following Cataract SurgeryProcedure: Microcoaxial Phacoemulsificationhttps://ClinicalTrials.gov/show/NCT01664689
6891368913Effects of Liraglutide on Kidney Function in Type 2 Diabetic PatientsCompletedNo Results AvailableType 2 Diabetes MellitusDrug: Liraglutide|Drug: Placebo-liraglutidehttps://ClinicalTrials.gov/show/NCT01664676
6891468914Phase II Randomized Study on Locally Advanced NSCLC Escalated Dose on Individual Basis Treatment With RadiochemotherapyTerminatedNo Results AvailableNon Small Cell Lung Cancer|Locally Advanced DiseaseRadiation: Standard radiochemotherapy to 68 Gy|Radiation: Dose escalated radiochemotherapy up to 84 Gyhttps://ClinicalTrials.gov/show/NCT01664663
6891568915Effects of Genistein in Postmenopausal Women With Metabolic SyndromeCompletedNo Results AvailableMetabolic SyndromeDietary Supplement: Genistein|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT01664650
6891668916Diabetic Gastroparesis Efficacy/Safety Study of TZP-102TerminatedNo Results AvailableDiabetic GastroparesisDrug: 10 mg TZP-102|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01664637
6891768917Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 DiabetesCompletedHas ResultsType 2 DiabetesDrug: Roflumilast|Drug: Alogliptin|Drug: Exenatide|Drug: Placebo to roflumilast|Drug: Placebo to alogliptinhttps://ClinicalTrials.gov/show/NCT01664624
6891868918Daily REmote Ischaemic Conditioning Following Acute Myocardial InfarctionRecruitingNo Results AvailablePost Myocardial InfarctionProcedure: Remote Ischaemic Conditioning administered via the inflation of a blood pressure cuff on the upper arm|Procedure: Sham conditioninghttps://ClinicalTrials.gov/show/NCT01664611
6891968919An Extension Study of WA19926 of the Long-Term Safety of RoActemra/Actemra (Tocilizumab) in Patients With Early Moderate to Severe Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid ArthritisDrug: tocilizumab [RoActemra/Actemra]https://ClinicalTrials.gov/show/NCT01664598
6892068920Exercise Training With Physically Active Lifestyle to Reduce Headache and Quality of LifeActive, not recruitingNo Results AvailableHeadache|Physical Activity|Quality of LifeBehavioral: Training group|Behavioral: Controlhttps://ClinicalTrials.gov/show/NCT01664585
6892168921Methodological Issues and Laser Speckle Contrast ImagingRecruitingNo Results AvailableMicrovascular Functionhttps://ClinicalTrials.gov/show/NCT01664572
6892268922Pain Control for Intrauterine Device Placement: A Trial of Ketorolac Prior to Intrauterine Device PlacementCompletedNo Results AvailablePain Control With IUD InsertionDrug: Ketorolac|Drug: Normal Salinehttps://ClinicalTrials.gov/show/NCT01664559
6892368923Study of the Best Blastocyst Post Transfer by aCGHNot yet recruitingNo Results AvailablePregnancy|Spontaneous Abortions|StillbirthProcedure: Trophectoderm biopsyhttps://ClinicalTrials.gov/show/NCT01664546
6892468924An Observational Study of Tarceva as Second-Line Treatment in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer After Pemetrexed in First-Line (TIME)CompletedNo Results AvailableNon-Squamous Non-Small Cell Lung Cancerhttps://ClinicalTrials.gov/show/NCT01664533
6892568925Dexmedetomidine and Subarachnoid HaemorrhageRecruitingNo Results AvailableSubarachnoid Hemorrhage|AneurysmDrug: Dexmedetomidine infusionhttps://ClinicalTrials.gov/show/NCT01664520
6892668926The Effect and Safety of Low Dose Nebulized Epinephrine in CroupNot yet recruitingNo Results AvailableCroup|Epinephrine Neublizer TreatmentDrug: conventional dose epinephrine|Drug: low dose epinephrinehttps://ClinicalTrials.gov/show/NCT01664507
6892768927An Observational Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer, Colon Cancer in the Adjuvant Setting, Advanced Gastric Cancer or Breast CancerCompletedNo Results AvailableBreast Cancer, Colorectal Cancer, Gastric Cancerhttps://ClinicalTrials.gov/show/NCT01664494
6892868928Gene Electrotransfer to Muscle With Plasmid AMEP in Patients With Disseminated CancerTerminatedNo Results AvailableMetastatic Malignant NeoplasmDrug: Plasmid AMEPhttps://ClinicalTrials.gov/show/NCT01664273
6892968929Efficacy Mechanism of N-acetylcysteine in Patients With Posttraumatic Stress DisorderRecruitingNo Results AvailablePosttraumatic Stress DisorderDrug: N-acetylcysteine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01664260
6893068930The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment IntensificationCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 2Drug: insulin degludec|Drug: liraglutide|Drug: placebohttps://ClinicalTrials.gov/show/NCT01664247
6893168931Oxygen Insuflation and ArterialDesaturation During Tracheal Intubation in ChildrenRecruitingNo Results AvailableInfants|Difficult AirwayOther: laryngoscopy with oxygen|Other: laryngoscopy without oxygenhttps://ClinicalTrials.gov/show/NCT01664234
6893268932PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy Subjects.Not yet recruitingNo Results AvailableHealthyDrug: Epoetin Alfahttps://ClinicalTrials.gov/show/NCT01664221
6893368933PK and PD Study After Single Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy SubjectsNot yet recruitingNo Results AvailableHealthyDrug: Epoetin Alfahttps://ClinicalTrials.gov/show/NCT01664195
6893468934Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney CancerRecruitingNo Results AvailableRecurrent Renal Cell Carcinoma|Stage III Renal Cell Cancer|Stage IV Renal Cell CancerBiological: Bevacizumab|Other: Laboratory Biomarker Analysis|Drug: Pazopanib Hydrochloride|Other: Pharmacological Study|Drug: Sorafenib Tosylate|Drug: Sunitinib Malate|Biological: Trebananibhttps://ClinicalTrials.gov/show/NCT01664182
6893568935Biomarkers in Plasma Specimens From Patients Treated on Study CALGB-80303WithdrawnNo Results AvailablePancreatic CancerOther: enzyme-linked immunosorbent assay|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01664169
6893668936Effect of Korean Red Ginseng on Women With Cold Hypersensitivity of Hands and FeetCompletedNo Results AvailableCold HypersensitivityDrug: Korean red ginseng|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01664156
6893768937A Single-Center Study of RO5508887 in Healthy VolunteersCompletedNo Results AvailableHealthy VolunteerDrug: Placebo|Drug: RO5508887https://ClinicalTrials.gov/show/NCT01664143
6893868938High-Dose Stereotactic Radiation for Prostate CancerActive, not recruitingNo Results AvailableAdenocarcinoma of the Prostate|Recurrent Prostate Cancer|Stage I Prostate Cancer|Stage IIA Prostate Cancer|Stage IIB Prostate Cancer|Stage III Prostate CancerRadiation: stereotactic body radiation therapy|Procedure: quality-of-life assessment|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01664130
6893968939An Observational Study in Clinical Practice Management of Patients With Biological Drugs in MonotherapyCompletedNo Results AvailableRheumatoid Arthritishttps://ClinicalTrials.gov/show/NCT01664117
6894068940An Observational Study to Evaluate RoActemra/Actemra (Tocilizumab) Treatment in a Real-Life SettingCompletedNo Results AvailableRheumatoid Arthritishttps://ClinicalTrials.gov/show/NCT01664104

* Görseller ve İçerik tekif hakkına sahip olabilir